Jabil Inc vs Kenvue Inc. Common Stock — how do they compare? Jabil Inc trades at $305.59 (market cap $31.35B), while Kenvue Inc. Common Stock trades at $17.72 (market cap $34.06B). The key difference: Jabil Inc and Kenvue Inc. Common Stock are close in size by market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| JBL | KVUE | |
|---|---|---|
Market Cap | $31.35B | $34.06B |
Volume | 1,337,978 | 23,267,228 |
Sector | Technology | Consumer Staples |
52-Week High | $385.50 | $19.83 |
52-Week Low | $192.49 | $14.11 |
Typical Hold Time | 23 Days | — |
Enterprise Value | $33.63B | $41.56B |
Dividend Yield | 0.11% | 4.74% |
Signals from Pluang's Aura AI — not financial advice
JBL trades at $301.76, up 0.76% today, with a bearish technical signal despite strong earnings beats in recent quarters. The stock shows robust fundamentals with revenue growth to $29.80B in 2025 and a high ROE of 74.11%, though net margins are thin at 2.9%. AI infrastructure demand is driving optimistic fiscal 2027 guidance, with a consensus analyst price target of $434.75 implying significant upside.
The outlook is positive due to accelerating AI-led growth and strong analyst support, but risks include market volatility post-earnings and high valuation multiples. Investment appeal hinges on execution of projected 24% revenue growth, while current technical weakness may present a buying opportunity for long-term investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →